Defibrillators give little help to sicker patients

	Tweet

Implantable defibrillators, which protect against deadly heart rhythms, may offer little benefit for older people who have other serious health problems at the time of heart failure, U.S. researchers said on Monday.

They said implantable heart defibrillators—which detect abnormal heart rhythms and deliver a life-saving shock to restore a regular beat—provide their greatest benefits for people under age 65 who have few other health complications.

“What we found was older patients with co-morbidities, such as chronic kidney disease, cancer and dementia—those patients are less likely to benefit,” said Dr. Soko Setoguchi of Harvard Medical School and Brigham and Women’s Hospital in Boston, whose study appears in the Canadian Medical Association Journal.

"Patients with multiple hospitalizations are also unlikely to benefit,” Setoguchi said in a telephone interview.

Implantable defibrillators, which cost between $20,000 to $30,000 to implant, are recommended for people with heart failure to prevent sudden cardiac death, which occurs when the heart stops circulating blood.

An estimated 5.3 million Americans suffer from heart failure, a chronic disease in which the heart gradually loses its ability to pump blood efficiently. The American Heart Association estimates the disease cost the United States $34.8 billion last year in direct and indirect treatment costs.

Many clinical trials have found the defibrillators to be life-saving and cost-effective devices, but such studies tended to exclude people with other health complications, Setoguchi said.

Her team’s findings were based on records from more than 14,000 people in Canada with heart failure. The average age of the study group was 77 and many also had heart disease, diabetes, chronic lung disease and kidney disease.

Everyone in the group had been hospitalized at least once for heart failure.

Setoguchi and her colleagues found that having a defibrillator prolonged lives by just over six months in half of the patients, and that this benefit shrank with each subsequent hospital admission.

She said people under 65 and older patients without kidney disease, cancer or dementia would be most likely to benefit from implantable defibrillators and that doctors could use the findings, which need to be confirmed, to advise patients.

By Julie Steenhuysen
CHICAGO (Reuters)

RELATED STORIES:
Scientists turn skin cells into beating heart muscle   Too many people get angioplasties, study suggests   New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA   Heart Damage After Chemo Linked to Stress in Cardiac Cells   What’s good or bad for the heart, may be the same for the brain   Warfarin in Heart Failure   Increased Sudden Cardiac Death Rate Among HIV Patients   Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease   Lack of basic evidence hampering prevention of sudden heart attacks in sport   Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study   Heart attack patients taken to PCI hospitals first treated faster   Cameron Health’s under-skin ICD safe, effective

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]